The IGF system in cancer should be examined in the context of the extra-cellular and intra-cellular signaling networks, particularly phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt/PKB), mammalian target of rapamycin (mTOR), and forkhead transcription factors (FOXO) [50]. This evidence concerns the gene AKT1 and cancer.